Infinimmune has raised $75m in Series A financing, helping the biotech advance its atopic dermatitis (AD)-centric pipeline. As part of the round, Infinimmune garnered the interest ...

Infinimmune Raises $75 Million Series A Financing to Advance Pipeline of Human-Derived Antibodies for Atopic Dermatitis and Inflammatory Disease ...

Infinimmune, a California startup, is developing treatments it claims might last longer and be more effective than existing atopic dermatitis medications.

It can be challenging to exercise with atopic dermatitis, the most common form of eczema. Find out what experts recommend to ...

Early respiratory infections were associated with childhood atopic dermatitis across two birth cohorts. Read more about the ...

If you have atopic dermatitis, the most common form of eczema, you may have noticed dark patches or light spots on your skin. This discoloration, which tends to linger after a flare, can be very ...

Red, itchy, and scaly skin from atopic dermatitis and eczema can be uncomfortable, confusing, and all too familiar. These chronic (meaning they can last a long time) inflammatory conditions can appear ...

Dry skin, raised bumps or a rash, and itchiness can all be symptoms of atopic dermatitis (AD), the most common type of eczema. AD affects about 16.5 million adults in the United States. Perhaps ...

Atopic dermatitis is a chronic inflammatory skin disease that causes extreme dryness, itchy rashes, scaly patches, and blisters that can ooze, crust, and flake. It affects people of all ages, all over ...

More than 16 million American adults, and 9.6 million American kids, live with atopic dermatitis. This condition, which is the most common form of eczema, can dramatically impact your quality of life.

Atopic dermatitis, often known as eczema, happens in people of all races and socioeconomic backgrounds. But research suggests that it’s more common in people of color, and more severe in both Black ...